e-learning
resources
Virtual 2020
Pre-Congress Content
Asthma and cough: clinical trials and pharmacological insights
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Blood eosinophil count as a predictor of treatment response in adult patients with chronic cough
A. Rybka (Warsaw, Poland), M. Dabrowska (Warsaw, Poland), E. Grabczak (Warsaw, Poland), K. Bialek-Gosk (Warsaw, Poland), K. Klimowicz (Warsaw, Poland), O. Truba (Warsaw, Poland), R. Krenke (Warsaw, Poland)
Source:
Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights
Session:
Asthma and cough: clinical trials and pharmacological insights
Session type:
E-poster session
Number:
2270
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Rybka (Warsaw, Poland), M. Dabrowska (Warsaw, Poland), E. Grabczak (Warsaw, Poland), K. Bialek-Gosk (Warsaw, Poland), K. Klimowicz (Warsaw, Poland), O. Truba (Warsaw, Poland), R. Krenke (Warsaw, Poland). Blood eosinophil count as a predictor of treatment response in adult patients with chronic cough. 2270
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Blood eosinophil count and exacerbation risk in patients with COPD
Source: Eur Respir J, 50 (1) 1700761; 10.1183/13993003.00761-2017
Year: 2017
Blood eosinophil (EOS) count, exacerbation rate and response to roflumilast in patients with severe COPD
Source: International Congress 2017 – What is new in COPD management and prognosis: findings from large studies?
Year: 2017
Association between blood eosinophil count and risk of exacerbations in patients with COPD
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017
Effect of COPD exacerbations on early lung function decline under maintenance therapy: blood eosinophil count asbiomarker
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019
Neutrophil count trends in BAL samples from children being investigated for chronic cough
Source: Annual Congress 2012 - Airway infections in children: from risk factors to treatment
Year: 2012
Correlations between exacerbation rate and blood eosinophil levels in COPD patients
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017
Elevated blood eosinophils on admission for a severe exacerbation of COPD is not a predictor for survival
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017
Clinical variables and protein biomarkers associated with blood eosinophil count and asthma in young adults
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021
The blood eosinophil count as a biomarker in COPD
Source: International Congress 2015 – Individualised risk reduction strategies for patients with COPD
Year: 2015
FE
NO
and blood eosinophil count as surrogate barkers of eosinophilic airway inflammation in patients with severe asthma
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
Systemic inflammation, blood eosinophils count and lung function in COPD patients
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017
Blood eosinophil counts in COPD patients compared to controls
Source: Eur Respir J, 54 (4) 1900633; 10.1183/13993003.00633-2019
Year: 2019
Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA)
Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma
Year: 2020
Association between blood eosinophil counts and risk of rehospitalization in patients with asthma
Source: International Congress 2017 – Monitoring novel biomarkers in asthma
Year: 2017
Blood eosinophil count: a biomarker of an important treatable trait in patients with airway disease
Source: Eur Respir J 2016; 47:1299-1303
Year: 2016
Blood eosinophil count and risk of pneumonia hospitalisations in individuals with COPD
Source: Eur Respir J, 51 (5) 1800120; 10.1183/13993003.00120-2018
Year: 2018
Blood eosinophil count as a predictor of obstructive airway disease (OAD) in a high parasite burden setting
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016
Mepolizumab does not alter blood basophil count in severe asthma
Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Year: 2019
Blood eosinophil count predicts treatment failure and hospital readmission for COPD
Source: ERJ Open Res, 6 (4) 00188-2020; 10.1183/23120541.00188-2020
Year: 2020
Peripheral blood eosinophil counts and serum total IgE on broncholdilator responsiveness in patients with stable COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 279s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept